Medical outcome in epilepsy patients of young adulthood-A 5-year follow-up study

Seizure

Volumn 18, Issue 4, 2009, Pages 293-297

  Gauffin, Helena ^a   Raty, Lena ^b   Söderfeldt, Birgitta ^c  

^a Department of Neurology ^*  (Sweden)

^b KARLSTAD UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epilepsy; Medical outcome; Quality of life; Young adults

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ADULT; ANAPHYLAXIS; ARTICLE; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONTROLLED STUDY; DRUG USE; EPILEPSY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63249122285     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2008.11.009     Document Type: Article

References (31)

1. Sillanpää M., and Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 129 (2006) 617-624
2. Moran N.F., Poole K., Bell G., Solomon J., Kendall S., McCarthy M., et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 13 (2004) 425-433
3. Raty L.K., Soderfeldt B.A., Larsson G., and Larsson B.M. The relationship between illness severity, sociodemographic factors, general self-concept, and illness-specific attitude in Swedish adolescents with epilepsy. Seizure 13 (2004) 375-382
4. Raty L.K., Wilde-Larsson B., and Soderfeldt B.A. Seizures and therapy in adolescents with uncomplicated epilepsy. Seizure 12 (2003) 229-236
5. Raty L.K., Larsson G., Soderfeldt B.A., and Larsson B.M. Psychosocial aspects of health in adolescence: the influence of gender, and general self-concept. J Adolesc Health 36 (2005) 530
6. Raty L.K., Wilde Larsson B.M., and Soderfeldt B.A. Health-related quality of life in youth: a comparison between adolescents and young adults with uncomplicated epilepsy and healthy controls. J Adolesc Health 33 (2003) 252-258
7. Lhatoo S.D., Sander J.W., and Shorvon S.D. The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years. J Neurol Neurosurg Psychiatry 71 (2001) 632-637
8. Bialer M. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin Investig Drugs 15 (2006) 637-647
9. Stefan H., and Feuerstein T.J. Novel anticonvulsant drugs. Pharmacol Ther 113 (2007) 165-183
10. Hitiris N., and Brodie M.J. Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 19 (2006) 175-180
11. Brodie M.J., and French J.A. Management of epilepsy in adolescents and adults. Lancet 356 (2000) 323-329
12. Tomson T. Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated?. J Neurol 251 (2004) 1043-1049
13. Falip M., Artazcoz L., de la Pena P., Perez-Sempere A., Martin-Moro M., and Codina M. Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions. Neurologia 20 (2005) 71-76
14. Hui A.C., Wong A., Wong H.C., Man B.L., Au-Yeung K.M., and Wong K.S. Refractory epilepsy in a Chinese population. Clin Neurol Neurosurg (2007) 672-675
15. Raty L.K., Soderfeldt B.A., and Wilde Larsson B.M. Daily life in epilepsy: patients' experiences described by emotions. Epilepsy Behav 10 (2007) 389-396
16. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30:389-99.
17. Eriksson K.J., and Koivikko M.J. Prevalence, classification, and severity of epilepsy and epileptic syndromes in children. Epilepsia 38 (1997) 1275-1282
18. Palmieri C., and Canger R. Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?. CNS Drugs 16 (2002) 755-764
19. Brodie M.J. Major congenital malformations and antiepileptic drugs: prospective observations. J Neurol Neurosurg Psychiatry 77 (2006) 145
20. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47 (2005) 551-555
21. Duncan S. Teratogenesis of sodium valproate. Curr Opin Neurol 20 (2007) 175-180
22. Aldenkamp A.P., Arends J., Bootsma H.P., Diepman L., Hulsman J., Lambrechts D., et al. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 43 (2002) 19-26
23. Chris Sackellares J., Jacqueline Kwong W., Vuong A., Hammer A.E., and Barrett P.S. Lamotrigine monotherapy improves health-related quality of life in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 3 (2002) 376-382
24. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1000-1015
25. Jacoby A., and Baker G.A. Quality-of-life trajectories in epilepsy: a review of the literature. Epilepsy Behav 12 4 (2008) 657-671
26. Guekht A.B., Mitrokhina T.V., Lebedeva A.V., Dzugaeva F.K., Milchakova L.E., Lokshina O.B., et al. Factors influencing on quality of life in people with epilepsy. Seizure 16 (2007) 128-133
27. Senol V., Soyuer F., Arman F., and Ozturk A. Influence of fatigue, depression, and demographic, socioeconomic, and clinical variables on quality of life of patients with epilepsy. Epilepsy Behav 10 (2007) 96-104
28. Perucca E., and Meador K.J. Adverse effects of antiepileptic drugs. Acta Neurol Scand 181 Suppl. (2005) 30-35
29. Benavente-Aguilar I., Morales-Blanquez C., Rubio E.A., and Rey J.M. Quality of life of adolescents suffering from epilepsy living in the community. J Paediatr Child Health 40 (2004) 110-113
30. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., and Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 62 (2004) 258-261
31. Hessen E., Lossius M.I., Reinvang I., and Gjerstad L. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy. Epilepsy Behav 10 (2007) 449-455